{"database": "lobbying", "table": "lobbying_activities", "rows": [[1876134, "29cc556f-98a2-457e-b398-00f3ff4c319c", "3A", "AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES", 1524, "AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOO", 2016, "third_quarter", "MED", "Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act, H.R. 5325\n\nCost-recovery regarding implementation of guidance issued by the Food and Drug Administration entitled, \"Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components\"", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2016-10-13T09:04:44.030000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1876134"], "units": {}, "query_ms": 6.550054997205734, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}